UK Parliament / Open data

Medicines and Medical Devices Bill

With this it will be convenient to discuss the following:

Amendment 21, in clause 1, page 2, line 6, at end insert—

“(5) In making regulations under subsection (1), the appropriate authority must give primary regard to the safety of human medicines.”

This amendment requires the appropriate authority to consider patient safety first when making regulations under subsection (1).

Amendment 20, page 1, line 5, at end insert

“for a period of three years following the day on which this Act is passed.”

This amendment provides a sunset provision for the Bill requiring the Government to return with primary legislation.

Amendment 19, in clause 2, page 2, line 26, at end, insert—

“(o) the origin and treatment of human organs used in the process of developing or manufacturing medicines”.

This amendment empowers the appropriate authority to make provisions on the process of developing or manufacturing medicines in relation to the origin and treatment of human organs.

Amendment 22, in clause 8, page 5, line 34, at end insert—

“(5) In making regulations under subsection (1), the appropriate authority must give primary regard to the safety of veterinary medicines in relation to animals, humans and the environment.”

This amendment requires the appropriate authority to consider animal, human and environmental safety first when making regulations under subsection (1).

Amendment 23, in clause 12, page 7, line 27, at end insert—

“(3) In making regulations under subsection (1), the appropriate authority must give primary regard to the safety of medical devices.”

This amendment requires the appropriate authority to consider safety first when making regulations under subsection (1).

Government amendments 1 to 18.

About this proceeding contribution

Reference

677 c1220 

Session

2019-21

Chamber / Committee

House of Commons chamber
Back to top